Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 14

1.

Validation of a novel multibiomarker test to assess rheumatoid arthritis disease activity.

Curtis JR, van der Helm-van Mil AH, Knevel R, Huizinga TW, Haney DJ, Shen Y, Ramanujan S, Cavet G, Centola M, Hesterberg LK, Chernoff D, Ford K, Shadick NA, Hamburger M, Fleischmann R, Keystone E, Weinblatt ME.

Arthritis Care Res (Hoboken). 2012 Dec;64(12):1794-803. doi: 10.1002/acr.21767.

2.

Rheumatoid arthritis disease activity measures: American College of Rheumatology recommendations for use in clinical practice.

Anderson J, Caplan L, Yazdany J, Robbins ML, Neogi T, Michaud K, Saag KG, O'Dell JR, Kazi S.

Arthritis Care Res (Hoboken). 2012 May;64(5):640-7. doi: 10.1002/acr.21649. Review.

3.

[New assessment method in rheumatoid arthritis].

Hirata S, Tanaka Y.

Nihon Rinsho. 2016 Jun;74(6):931-7. Review. Japanese.

PMID:
27311181
4.

The development of the disease activity score (DAS) and the disease activity score using 28 joint counts (DAS28).

van Riel PL.

Clin Exp Rheumatol. 2014 Sep-Oct;32(5 Suppl 85):S-65-74. Epub 2014 Oct 30. Review.

PMID:
25365092
5.

Vectra DA for the objective measurement of disease activity in patients with rheumatoid arthritis.

Segurado OG, Sasso EH.

Clin Exp Rheumatol. 2014 Sep-Oct;32(5 Suppl 85):S-29-34. Epub 2014 Oct 30. Review.

PMID:
25365086
6.

The value of C-reactive protein measurement in rheumatoid arthritis.

Otterness IG.

Semin Arthritis Rheum. 1994 Oct;24(2):91-104. Review.

PMID:
7839158
7.
8.

Disease activity measures for rheumatoid arthritis.

Dougados M, Aletaha D, van Riel P.

Clin Exp Rheumatol. 2007 Sep-Oct;25(5 Suppl 46):S22-9. Review.

PMID:
17977485
9.
10.

Methodological issues in radiographic scoring methods in rheumatoid arthritis.

van der Heijde D, Boers M, Lassere M.

J Rheumatol. 1999 Mar;26(3):726-30. Review.

PMID:
10090191
11.

C-reactive protein in rheumatology: biology and genetics.

Rhodes B, Fürnrohr BG, Vyse TJ.

Nat Rev Rheumatol. 2011 May;7(5):282-9. doi: 10.1038/nrrheum.2011.37. Epub 2011 Apr 5. Review.

PMID:
21468143
12.

Testing of the OMERACT 8 draft validation criteria for a soluble biomarker reflecting structural damage in rheumatoid arthritis: a systematic literature search on 5 candidate biomarkers.

Syversen SW, Landewe R, van der Heijde D, Bathon JM, Boers M, Bykerk VP, Fitzgerald O, Gladman DD, Garnero P, Geusens P, El-Gabalawy H, Inman RD, Kraus V, Kvien TK, Mease PJ, Ostergaard M, Ritchlin CJ, Tak PP, Taylor WJ, Maksymowych WP.

J Rheumatol. 2009 Aug;36(8):1769-84. doi: 10.3899/jrheum.090262. Review.

PMID:
19671812
13.

Oxidative Stress Relevance in the Pathogenesis of the Rheumatoid Arthritis: A Systematic Review.

Quiñonez-Flores CM, González-Chávez SA, Del Río Nájera D, Pacheco-Tena C.

Biomed Res Int. 2016;2016:6097417. doi: 10.1155/2016/6097417. Epub 2016 May 31. Review.

14.

Mass cytometry as a platform for the discovery of cellular biomarkers to guide effective rheumatic disease therapy.

Nair N, Mei HE, Chen SY, Hale M, Nolan GP, Maecker HT, Genovese M, Fathman CG, Whiting CC.

Arthritis Res Ther. 2015 May 18;17:127. doi: 10.1186/s13075-015-0644-z. Review.

Supplemental Content

Support Center